Golden State Wealth Management’s Diageo DEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$67.5K Hold
840
0.01% 661
2026
Q1
$62.5K Hold
840
0.01% 631
2025
Q4
$72.5K Sell
840
-566
-40% -$52.1K 0.01% 596
2025
Q3
$134K Buy
1,406
+392
+39% +$41.1K 0.01% 441
2025
Q2
$102K Buy
1,014
+27
+3% +$2.93K 0.01% 473
2025
Q1
$103K Hold
987
0.02% 433
2024
Q4
$125K Buy
+987
New +$126K 0.02% 393
2022
Q1
$203K Hold
998
0.04% 296
2021
Q4
$220K Sell
998
-116
-10% -$23.8K 0.04% 341
2021
Q3
$215K Hold
1,114
0.05% 281
2021
Q2
$214K Buy
+1,114
New +$207K 0.05% 274
2020
Q4
Sell
-1,136
Closed -$156K 272
2020
Q3
$156K Buy
+1,136
New +$157K 0.05% 213
2020
Q2
Sell
-1,066
Closed -$136K 342
2020
Q1
$136K Buy
+1,066
New +$160K 0.06% 210
2019
Q4
Sell
-1,044
Closed -$171K 241
2019
Q3
$171K Hold
1,044
0.06% 223
2019
Q2
$179K Sell
1,044
-48
-4% -$8.07K 0.06% 239
2019
Q1
$179K Buy
+1,092
New +$167K 0.06% 241

Other funds holding DEO

Golden State Wealth Management's DEO Position: Q2 2026 in Review

Golden State Wealth Management held its Diageo (DEO) position steady in Q2 2026 at 840 shares worth $67.5K. The position accounts for 0.01% of the portfolio, ranked #661.

Golden State Wealth Management first reported a position in DEO in Q1 2019 and has held it in 16 quarters since. The position peaked at $220K in Q4 2021. 720 funds tracked by Wall St. Rank hold DEO as of Q2 2026.

  • Golden State Wealth Management held 840 shares of Diageo worth $67.5K as of Q2 2026.
  • Golden State Wealth Management left its Diageo share count unchanged in Q2 2026.
  • Diageo made up 0.01% of Golden State Wealth Management's portfolio in Q2 2026, its #661 holding.
  • Golden State Wealth Management first reported a position in Diageo in Q1 2019 and has held it in 16 quarters since.
  • Golden State Wealth Management's Diageo position peaked at $220K in Q4 2021.
  • 720 funds tracked by Wall St. Rank held Diageo as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.